Icecure Medical Stock Alpha and Beta Analysis

ICCM Stock  USD 0.71  0.11  18.33%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Icecure Medical. It also helps investors analyze the systematic and unsystematic risks associated with investing in Icecure Medical over a specified time horizon. Remember, high Icecure Medical's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Icecure Medical's market risk premium analysis include:
Beta
(0.12)
Alpha
0.18
Risk
5.2
Sharpe Ratio
0.0331
Expected Return
0.17
Please note that although Icecure Medical alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, Icecure Medical did 0.18  better than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Icecure Medical stock's relative risk over its benchmark. Icecure Medical has a beta of 0.12  . As returns on the market increase, returns on owning Icecure Medical are expected to decrease at a much lower rate. During the bear market, Icecure Medical is likely to outperform the market. At this time, Icecure Medical's Price Book Value Ratio is very stable compared to the past year. As of the 24th of November 2024, Price Fair Value is likely to grow to 4.22, while Book Value Per Share is likely to drop 0.25.

Enterprise Value

36.95 Million

Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out Icecure Medical Backtesting, Icecure Medical Valuation, Icecure Medical Correlation, Icecure Medical Hype Analysis, Icecure Medical Volatility, Icecure Medical History and analyze Icecure Medical Performance.
To learn how to invest in Icecure Stock, please use our How to Invest in Icecure Medical guide.

Icecure Medical Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Icecure Medical market risk premium is the additional return an investor will receive from holding Icecure Medical long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Icecure Medical. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Icecure Medical's performance over market.
α0.18   β-0.12

Icecure Medical expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Icecure Medical's Buy-and-hold return. Our buy-and-hold chart shows how Icecure Medical performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Icecure Medical Market Price Analysis

Market price analysis indicators help investors to evaluate how Icecure Medical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Icecure Medical shares will generate the highest return on investment. By understating and applying Icecure Medical stock market price indicators, traders can identify Icecure Medical position entry and exit signals to maximize returns.

Icecure Medical Return and Market Media

The median price of Icecure Medical for the period between Mon, Aug 26, 2024 and Sun, Nov 24, 2024 is 0.62 with a coefficient of variation of 11.83. The daily time series for the period is distributed with a sample standard deviation of 0.08, arithmetic mean of 0.64, and mean deviation of 0.05. The Stock received substential amount of media coverage during this period.
 Price Growth (%)  
       Timeline  
1
FDA AdComm to discuss IceCures ProSense on Nov. 7
09/12/2024
2
Study Published in the British Journal of Radiology Demonstrates IceCures ProSense is a Safe Procedure with 97.7 percent Technical Success Rate in Treating Tumo...
09/16/2024
3
Zacks.com featured highlights Adverum Biotechnologies, IceCure, DarioHealth, Energous and Virgin Galactic
10/03/2024
4
Short Interest in IceCure Medical Ltd Decreases By 6.1
10/16/2024
5
IceCure gets favorable FDA AdCom vote for ProSense System
11/08/2024
6
Market Sentiment Around Loss-Making IceCure Medical Ltd
11/13/2024
7
IceCure Medical to Report Third Quarter 2024 Financial Operational Results on November 26, 2024
11/20/2024

About Icecure Medical Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Icecure or other stocks. Alpha measures the amount that position in Icecure Medical has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2022 2023 2024 (projected)
Payables Turnover2.33.843.52
Days Of Inventory On Hand635.86430.47259.86

Icecure Medical Upcoming Company Events

As portrayed in its financial statements, the presentation of Icecure Medical's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Icecure Medical's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Icecure Medical's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Icecure Medical. Please utilize our Beneish M Score to check the likelihood of Icecure Medical's management manipulating its earnings.
3rd of April 2024
Upcoming Quarterly Report
View
27th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
3rd of April 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Build Portfolio with Icecure Medical

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether Icecure Medical is a strong investment it is important to analyze Icecure Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Icecure Medical's future performance. For an informed investment choice regarding Icecure Stock, refer to the following important reports:
Check out Icecure Medical Backtesting, Icecure Medical Valuation, Icecure Medical Correlation, Icecure Medical Hype Analysis, Icecure Medical Volatility, Icecure Medical History and analyze Icecure Medical Performance.
To learn how to invest in Icecure Stock, please use our How to Invest in Icecure Medical guide.
You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Icecure Medical technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Icecure Medical technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Icecure Medical trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...